Malcolm Brenner, MD
The Methodist Hospital Research Institute · Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Malcolm Brenner, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:14 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT01192555 · Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk NeuroblastomaBaylor College of Medicine · active not recruiting · Neuroblastoma · principal investigator
- Ph1/Ph2NCT00579137 · Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency DisordersBaylor College of Medicine · terminated · Severe Combined Immunodeficiency Disease, Severe Primary Immunodeficiency Disorder, Undefined T Cell Deficiency Disorder · study chair
- Ph1NCT00062855 · Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory NeuroblastomaBaylor College of Medicine · completed · Neuroblastoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in neuroblastoma.